Complementary therapy for the treatment of glaucoma: A perspective

Ophthalmology Clinics of North America

Volumn 18, Issue 4, 2005, Pages 597-609

  Ritch, Robert ^a,b  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANGELICA SINENSIS EXTRACT; ANTIOXIDANT; ARCTIGENIN; ASCORBIC ACID; ASPILIA EXTRACT; CARNITINE; CARNOSINE; CATECHIN; COLEUS FORSKALII EXTRACT; CRATAEGUS EXTRACT; GINKGO BILOBA EXTRACT; GINKGOLIDE B; GINSENG EXTRACT; GINSENOSIDE; GLUTATHIONE; GREEN TEA EXTRACT; HERBACEOUS AGENT; NEUROPROTECTIVE AGENT; NITRIC OXIDE; PLANT EXTRACT; PYCNOGENOL; RESVERATROL; RETINOL ACETATE; SALVIA MILTIORRHIZA EXTRACT; SCHROPHULARIA BUERGERIANA EXTRACT; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINIUM MYRTILLUS EXTRACT;

ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; ANGINA PECTORIS; ANTIOXIDANT ACTIVITY; ASPILIA; BLOOD FLOW; CARDIOVASCULAR FUNCTION; CHRONIC DISEASE; CLINICAL TRIAL; COLEUS FORSKALII; CONGESTIVE HEART FAILURE; CURCUMA LONGA; DIABETIC RETINOPATHY; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG RESEARCH; EYE BLOOD FLOW; GINKGO BILOBA; GLAUCOMA; GRAPE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; IMMUNE SYSTEM; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCHROPHULARIA BUERGERIANA; WINE;

COMPLEMENTARY THERAPIES; GLAUCOMA; HUMANS; PHYTOTHERAPY; PLANT PREPARATIONS; TREATMENT OUTCOME;

EID: 28444471273     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ohc.2005.07.004     Document Type: Review

References (150)

1. Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS report No. 8 Arch Ophthalmol 119 2001 1417 1436
2. R. Ritch A potential role for Ginkgo biloba extract in the treatment of glaucoma Med Hypotheses 54 2000 221 235
3. Y. Christen Ginkgo biloba and neurodegenerative disorders Front Biosci 9 2004 3091 3104
4. F.V. Defeudis Bilobalide and neuroprotection Pharmacol Res 46 2002 565 568
5. B. Ahlemeyer, and J. Krieglstein Neuroprotective effects of Ginkgo biloba extract Cell Mol Life Sci 60 2003 1779 1792
6. K. Köse, and P. Dogan Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 2. Comparison of the antioxidant effect of Ginkgo biloba extract (EGb 761) with those of water-soluble and lipid-soluble antioxidants J Int Med Res 23 1995 9 18
7. D. Janssens, E. Delaive, and J. Remacle Protection by bilobalide of the ischaemia-induced alterations of the mitochondrial respiratory activity Fundam Clin Pharmacol 14 2000 193 201
8. S. Pierre, I. Jamme, and K. Robert GBE (EGb 761) protects Na,K-ATPase isoenzymes during cerebral ischemia Cell Mol Biol 48 2002 671 680
9. J. Sastre, A. Lloret, and C. Borras GBE EGb 761 protects against mitochondrial aging in the brain and in the liver Cell Mol Biol 48 2002 685 692
10. K. Chandrasekaran, Z. Mehrabian, and B. Spinnewyn Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761) in global brain ischemia and in excitotoxicity-induced neuronal death Pharmacopsychiatry 36 Suppl 1 2003 S89 S94
11. A. Eckert, U. Keil, and S. Kressmann Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress Pharmacopsychiatry 36 Suppl 1 2003 S15 S23
12. L. Marcocci, J.J. Maguire, and M.T. Droy-Lefaix The nitric oxide-scavenging properties of Ginkgo biloba extract (EGb 761) Biochem Biophys Res Commun 201 1994 748 755
13. H. Kobuchi, M.T. Droy-Lefaix, and Y. Christen Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7 Biochem Pharmacol 53 1997 897 904
14. P.F. Smith, K. Maclennan, and C.L. Darlington The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF) J Ethnopharmacol 50 1996 131 139
15. L. Zhu, J. Wu, and H. Liao Antagonistic effects of extract from leaves of Ginkgo biloba on glutamate neurotoxicity Acta Pharmacol Sin 18 1997 344 347
16. Y. Oyama, P.A. Fuchs, and N. Katayama Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons Brain Res 635 1994 125 129
17. S. Bastianetto, and R. Quirion EGb 761 is a neuroprotective agent against β-amyloid toxicity Cell Mol Biol 48 2002 693 698
18. C. Soulié, A. Nicole, and Y. Christen The GBE EGb 761 increases viability of hnt human neurons in culture and affects the expression of genes implicated in the stress response Cell Mol Biol 48 2002 641 646
19. C. Guidetti, S. Paracchini, and S. Lucchini Prevention of neuronal cell damage induced by oxidative stress in vitro: effect of different Ginkgo biloba extracts J Pharm Pharmacol 53 2001 387 392
20. L.J. Zhou, and X.Z. Zhu Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide J Pharmacol Exp Ther 293 2000 982 988
21. B. Ahlemeyer, A. Mowes, and J. Krieglstein Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents Eur J Pharmacol 367 1999 423 430
22. C. Bate, M. Salmona, and A. Williams Ginkgolide B inhibits the neurotoxicity of prions or amyloid-beta1-42 J Neuroinflammation 1 2004 4
23. S. Horsch, and C. Walther Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD)-a review based on randomized, controlled studies Int J Clin Pharmacol Ther 42 2004 63 72
24. M.H. Pittler, and E. Ernst Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials Am J Med 108 2000 276 281
25. M.H. Pittler, and E. Ernst Complementary therapies for peripheral arterial disease: systematic review Atherosclerosis 181 2005 1 7
26. N. Haramaki, S. Aggarwal, and T. Kawabata Effects of natural antioxidant Ginkgo biloba extract (EGb 761) on myocardial ischemia-reperfusion injury Free Radic Biol Med 16 1994 789 794
27. K. Punkt, K. Welt, and L. Schaffranietz Changes of enzyme activities in the rat myocardium caused by experimental hypoxia with and without Ginkgo biloba extract EGb 761 pretreatment. A cytophotometrical study Acta Histochem 97 1995 67 79
28. B. Hofferberth The efficacy of EGb 761 in patients with senile dementia of the Alzheimer type. A double-blind, placebo-controlled study on different levels of investigation Hum Psychopharmacol 9 1994 215 222
29. P.L. Le Bars, M.M. Katz, and N. Berman A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia JAMA 278 1997 1327 1332
30. M.T. Droy-Lefaix, M.E. Szabo-Tosaki, and M.N. Doly Free radical scavenger properties of EGb 761 on functional disorders induced by experimental diabetic retinopathy R.G. Cutler L. Packe J. Bertram A. Mori Oxidative stress and aging 1996 Birkhäuser Verlag Basel 277 286
31. M.E. Szabo, M.T. Droy-Lefaix, and M. Doly Modification of ischemia/reperfusion-induced ion shifts (Na+, K+, Ca2+ and Mg2+) by free radical scavengers in the rat retina Ophthalmic Res 25 1993 1
32. S.Y. Huang, C. Jeng, and S.C. Kao Improved hemorrheological properties by Ginkgo biloba extract (EGb 761) in type 2 diabetes mellitus complicated with retinopathy Clin Nutr 23 2004 615 621
33. G.B. Kudolo, D. Delaney, and J. Blodgett Short-term oral ingestion of Ginkgo biloba extract (EGb 761) reduces malondialdehyde levels in washed platelets of type 2 diabetic subjects Diabetes Res Clin Pract 68 2005 29 38
34. I. Ranchon, J.M. Gorrand, and J. Cluzel Functional protection of photoreceptors from light-induced damage by dimethyl thiourea and Ginkgo biloba extract Invest Ophthalmol Vis Sci 40 1999 1191 1199
35. G. Meyniel, M. Doly, and M. Millerin Involvement of PAF (platelet-activating factor) in chloroquine-induced retinopathy C R Acad Sci III 314 1992 61 65
36. M.T. Droy-Lefaix, M.E. Szabo, and M.N. Doly Ischaemia and reperfusion-induced injury in the retina obtained form normotensive and spontaneously hypertensive rats: effects of free radical scavengers Int J Tissue React 15 1993 85 91
37. K. Hirooka, M. Tokuda, and O. Miyamoto The Ginkgo biloba extract (EGb 761) provides neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma Curr Eye Res 28 2004 153 157
38. A. Raabe, M. Raabe, and P. Ihm Therapeutic follow-up using automatic perimetry in chronic cerebroretinal ischemia in elderly patients. Prospective double-blind study with graduated dose Ginkgo biloba treatment Klin Monatsbl Augenheilkd 199 1991 432 438
39. L. Quaranta, S. Bettelli, and M.G. Uva Effect of Ginkgo biloba extract on pre-existing visual field damage in normal tension glaucoma Ophthalmology 110 2003 359 364
40. H.S. Chung, A. Harris, and J.K. Kristinsson Ginkgo biloba extract increases ocular blood flow velocity J Ocular Pharmacol Therap 15 1999 233 240
41. S.D. Sarker, and L. Nahar Natural medicine: the genus Angelica Curr Med Chem 11 2004 1479 1500
42. Y. Xiaohong, O.Y. Jing-Ping, and T. Shuzheng Angelica protects the human vascular endothelial cell from the effects of oxidized low-density lipoprotein in vitro Clin Hemorrheol Microcirc 22 2000 317 323
43. H. Ding, R. Peng, and J. Yu Modulation of Angelica sinensis polysaccharides on the expression of nitric oxide synthase and Bax, Bcl-2 in liver of immunological liver-injured mice Zhonghua Gan Zang Bing Za Zhi 9 Suppl 2001 50 52
44. Y. Zhui, O.Y. Jing-Ping, and L. Yongming Experimental study of the antiatherogenesis effect of Chinese medicine Angelica and its mechanisms Clin Hemorrheol Microcirc 22 2000 305 310
45. M.K. Cho, J.W. Park, and Y.P. Jang Potent inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by dibenzylbutyrolactone lignans through inhibition of I-kappaBalpha phosphorylation and of p65 nuclear translocation in macrophages Int Immunopharmacol 2 2002 105 116
46. J.Y. Cho, A.R. Kim, and E.S. Yoo Immunomodulatory effect of arctigenin, a lignan compound, on tumour necrosis factor-alpha and nitric oxide production, and lymphocyte proliferation J Pharm Pharmacol 51 1999 1267 1273
47. Y.P. Jang, S.R. Kim, and Y.H. Choi Arctigenin protects cultured cortical neurons from glutamate-induced neurodegeneration by binding to kainate receptor J Neurosci Res 68 2002 233 240
48. M.M. Hanna, and J. Niemetz Studies on the anticoagulant action of Aspilia africana Thromb Res 47 1987 401 407
49. A.L. Miller Botanical influences on cardiovascular disease Altern Med Rev 3 1998 422 431
50. D.L. Zhang, Y.T. Zhang, and J.J. Yin Oral administration of Crataegus flavonoids protects against ischemia/reperfusion brain damage in gerbils J Neurochem 90 2004 211 219
51. S.P. Bartels, S.R. Lee, and A.H. Neufeld The effects of forskolin on cyclic AMP, intraocular pressure, and aqueous humor formation in rabbits Curr Eye Res 6 1987 307 320
52. R.F. Brubaker, K.H. Carlson, and L.J. Kullerstrand Topical forskolin (Colforsin) and aqueous flow in humans Arch Ophthalmol 105 1987 637 641
53. J. Caprioli, and M. Sears Forskolin lowers intraocular pressure in rabbits, monkeys, and man Lancet 1 1983 958 960
54. B.H. Meyer, A.A. Stulting, and F.O. Muller The effect of forskolin eye drops on intraocular pressure S Afr Med J 71 1987 570 571
55. C. Seto, S. Eguchi, and M. Araie Acute effects of topical forskolin on aqueous humor dynamics in man Jpn J Ophthalmol 30 1986 238 244
56. A.S. Attele, J.A. Wu, and C.S. Yuan Ginseng pharmacology: multiple constituents and multiple actions Biochem Pharmacol 58 1999 1685 1693
57. Y.C. Kim, S.R. Kim, and G.J. Markelonis Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration J Neurosci Res 53 1998 426 432
58. X.Y. Lian, Z. Zhang, and J.L. Stringer Protective effects of ginseng components in a rodent model of neurodegeneration Ann Neurol 57 2005 642 648
59. S. Kim, K. Ahn, and T.H. Oh Inhibitory effect of ginsenosides on NMDA receptor-mediated signals in rat hippocampal neurons Biochem Biophys Res Commun 296 2002 247 254
60. J.H. Lim, T.C. Wen, and S. Matsuda Protection of ischemic hippocampal neurons by ginsenoside Rb1, a main ingredient of ginseng root Neurosci Res 28 1997 191 200
61. Y.S. Chen, C.H. Wu, and C.H. Yao Ginsenoside Rb1 enhances peripheral nerve regeneration across wide gaps in silicone rubber chambers Int J Artif Organs 25 2002 1103 1108
62. J.Y. Cho, E.S. Yoo, and K.U. Baik In vitro inhibitory effect of protopanaxadiol ginsenosides on tumor necrosis factor (TNF)-alpha production and its modulation by known TNF-alpha antagonists Planta Med 67 2001 213 218
63. Y.C. Huang, C.T. Chen, and S.C. Chen A natural compound (ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration Pharm Res 22 2005 636 646
64. D. Bagchi, M. Bagchi, and S. Stohs Cellular protection with proanthocyanidins derived from grape seeds Ann NY Acad Sci 957 2002 260 270
65. J. Yamakoshi, M. Saito, and S. Kataoka Procyanidin-rich extract from grape seeds prevents cataract formation in hereditary cataractous (ICR/f) rats J Agric Food Chem 50 2002 4983 4988
66. M.V. Ertekin, I. Kocer, and I. Karslioglu Effects of oral Ginkgo biloba supplementation on cataract formation and oxidative stress occurring in lenses of rats exposed to total cranium radiotherapy Jpn J Ophthalmol 48 2004 499 502
67. T. Pataki, I. Bak, and P. Kovacs Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts Am J Clin Nutr 75 2002 894 899
68. Z.H. Shao, L.B. Becker, and T.L. Vanden Hoek Grape seed proanthocyanidin extract attenuates oxidant injury in cardiomyocytes Pharmacol Res 47 2003 463 469
69. D. Bagchi, C.K. Sen, and S.D. Ray Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract Mutat Res 523-524 2003 87 97
70. R. Kalin, A. Righi, and A. Del Rosso Activin, a grape seed-derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis Free Radic Res 36 2002 819 825
71. F. Natella, F. Belelli, and V. Gentili Grape seed proanthocyanidins prevent plasma postprandial oxidative stress in humans J Agric Food Chem 50 2002 7720 7725
72. M.P. Nair, C. Kandaswami, and S. Mahajan Grape seed extract proanthocyanidins downregulate HIV-1 entry coreceptors, CCR2b, CCR3 and CCR5 gene expression by normal peripheral blood mononuclear cells Biol Res 35 2002 421 431
73. S. Chanvitayapongs, B. Draczynska-Lusiak, and A.Y. Sun Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells Neuroreport 8 1997 1499 1502
74. E.N. Frankel, A.L. Waterhouse, and J.E. Kinsella Inhibition of human LDL oxidation by resveratrol Lancet 341 1993 1103 1104
75. S. Shigematsu, S. Ishida, and M. Hara Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants Free Radic Biol Med 34 2003 810 817
76. G.A. Losa Resveratrol modulates apoptosis and oxidation in human blood mononuclear cells Eur J Clin Invest 33 2003 818 823
77. H. Zhuang, Y.S. Kim, and R.C. Koehler Potential mechanism by which resveratrol, a red wine constituent, protects neurons Ann NY Acad Sci 993 2003 276 286
78. R.E. King, K.D. Kent, and J.A. Bomser Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibition Chem Biol Interact 151 2005 143 149
79. U. Kiziltepe, N.N. Turan, and U. Han Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury J Vasc Surg 40 2004 138 145
80. T. Sano, E. Oda, and T. Yamashita Anti-thrombotic effect of proanthocyanidin, a purified ingredient of grape seed Thromb Res 115 2005 115 121
81. J.V. Higdon, and B. Frei Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions Crit Rev Food Sci Nutr 43 2003 89 143
82. S.R. Lee, K.J. Im, and S.I. Suh Protective effect of green tea polyphenol (-)-epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates Phytother Res 17 2003 206 209
83. S. Mandel, and M.B.H. Youdim Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases Free Radic Biol Med 37 2004 304 317
84. T. Kakuda Neuroprotective effects of the green tea components theanine and catechins Biol Pharm Bull 25 2002 1513 1518
85. O. Weinreb, S. Mandel, and M.B. Youdim cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells FASEB J 17 2003 935 937
86. H. van Jaarsveld, J.M. Kuyl, and D.H. Schulenburg Effect of flavonoids on the outcome of myocardial mitochondrial ischemia/reperfusion injury Res Commun Mol Pathol Pharmacol 91 1996 65 75
87. T. Nakagawa, and T. Yokozawa Direct scavenging of nitric oxide and superoxide by green tea Food Chem Toxicol 40 2002 1745 1750
88. G. Thiagarajan, S. Chandani, and C.S. Sundari Antioxidant properties of green and black tea, and their potential ability to retard the progression of eye lens cataract Exp Eye Res 73 2001 393 401
89. S.K. Gupta, N. Halde, and S. Sivastava Green tea (Camellia sinensis) protects against selenite-induced oxidative stress in experimental cataractogenesis Ophthalmic Res 34 2002 258 263
90. P. Rohdewald A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology Int J Clin Pharmacol Ther 40 2002 158 168
91. M. Araghi-Niknam, S. Hosseini, and D. Larson Pine bark extract reduces platelet aggregation Integr Med 2 2000 73 77
92. S. Devaraj, S. Vega-Lopez, and N.S. Kaul Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile Lipids 37 2002 931 934
93. R. Koch Comparative study of Venostasin and Pycnogenol in chronic venous insufficiency Phytother Res 16 Suppl 1 2002 S1 S5
94. G. Blazso, M. Gabor, and F. Schonlau Pycnogenol accelerates wound healing and reduces scar formation Phytother Res 18 2004 579 581
95. M.S. Kobayashi, D. Han, and L. Packer Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity Free Radic Res 32 2000 115 124
96. F. Liu, B.H. Lau, and Q. Peng Pycnogenol protects vascular endothelial cells from beta-amyloid-induced injury Biol Pharm Bull 23 2000 735 737
97. Q.L. Peng, A.R. Buz'Zard, and B.H. Lau Pycnogenol protects neurons from amyloid-beta peptide-induced apoptosis Brain Res Mol Brain Res 104 2002 55 65
98. L. Packer, G. Rimbach, and F. Virgili Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol Free Radic Biol Med 27 1999 704 724
99. F. Schonlau, and P. Rohdewald Pycnogenol for diabetic retinopathy. A review Int Ophthalmol 24 2001 161 171
100. B.A. Dene, A.C. Maritim, and R.A. Sanders Effects of antioxidant treatment on normal and diabetic rat retinal enzyme activities J Ocul Pharmacol Ther 21 2005 28 35
101. T. Grimm, A. Schafer, and P. Hogger Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol) Free Radic Biol Med 15 2004 811 822
102. G. Belcaro, M.R. Cesarone, and P. Rohdewald Prevention of venous thrombosis and thrombophlebitis in long-haul flights with pycnogenol Clin Appl Thromb Hemost 10 2004 373 377
103. Y.H. Chen, S.J. Lin, and H.H. Ku Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells J Cell Biochem 82 2001 512 521
104. Y.J. Wu, C.Y. Hong, and S.J. Lin Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza Arterioscler Thromb Vasc Biol 18 1998 481 486
105. L.Q. Min, L.Y. Dang, and W.Y. Ma Clinical study on effect and therapeutical mechanism of composite Salvia injection on acute cerebral infarction Zhongguo Zhong Xi Yi Jie He Za Zhi 22 2002 353 355
106. B.Y. Lam, A.C. Lo, and X. Sun Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice Phytomedicine 10 2003 286 291
107. W.H. Zhang, J.S. Wang, and Y. Zhou Gadolinium chloride and Salvia miltiorrhiza compound ameliorate reperfusion injury in hepatocellular mitochondria World J Gastroenterol 9 2003 2040 2044
108. M.D. Zhu, and F.Y. Cai Evidence of compromised circulation in the pathogenesis of optic nerve damage in chronic glaucomatous rabbit Chin Med J (Engl) 106 1993 922 927
109. Z.Z. Wu, Y.Q. Jiang, and S.M. Yi Radix Salviae miltiorrhizae in middle and late-stage glaucoma Chin Med J (Engl) 96 1983 445 447
110. X. Sun, L.N. Chan, and X. Gong N-methyl-D-aspartate receptor antagonist activity in traditional Chinese stroke medicines Neurosignals 12 2003 31 38
111. X.J. Wang, Z.B. Wang, and J.X. Xu Effect of salvianic acid A on lipid peroxidation and membrane permeability in mitochondria J Ethnopharmacol 97 2005 441 445
112. S.R. Kim, K.Y. Lee, and K.A. Koo Four new neuroprotective iridoid glycosides from Schrophularia buergeriana roots J Nat Prod 65 2002 1696 1699
113. S.R. Kim, S.H. Sung, and Y.P. Jang E-p-methoxycinnamic acid protects cultured neuronal cells against neurotoxicity induced by glutamate Br J Pharmacol 135 2002 1281 1291
114. P.H. Canter, and E. Ernst Anthocyanosides of Vaccinium myrtillus (Bilberry) for night vision-a systematic review of placebo-controlled trials Surv Ophthalmol 49 2004 38 50
115. J.C. Tilak, M. Banerjee, and H. Mohan Antioxidant availability of turmeric in relation to its medicinal and culinary uses Phytother Res 18 2004 798 804
116. W.M. Weber, L.A. Hunsaker, and S.F. Abcouwer Anti-oxidant activities of curcumin and related enones Bioorg Med Chem 13 2005 3811 3820
117. S. Swarnakar, K. Ganguly, and P. Kundu Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer J Biol Chem 280 2005 9409 9415
118. P. Suryanarayana, M. Saraswat, and T. Mrudula Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats Invest Ophthalmol Vis Sci 46 2005 2092 2099
119. M. Llansola, S. Erceg, and M. Hernandez-Viadel Prevention of ammonia and glutamate neurotoxicity by carnitine: molecular mechanisms Metab Brain Dis 17 2002 389 397
120. I. Kocer, D. Kulacoglu, and I. Altuntas Protection of the retina from ischemia-reperfusion injury by L-carnitine in guinea pigs Eur J Ophthalmol 13 2003 80 85
121. P.J. Quinn, A.A. Boldyrev, and V.E. Formazuyk Carnosine: its properties, functions and potential therapeutic applications Mol Aspects Med 13 1992 379 444
122. V.P. Reddy, M.R. Garrett, and G. Perry Carnosine: a versatile antioxidant and antiglycating agent Sci Aging Knowledge Environ 18 2005 pe12
123. Y.T. Lee, C.C. Hsu, and M.H. Lin Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation Eur J Pharmacol 513 2005 145 150
124. T. Fujii, M. Takaoka, and N. Tsuruoka Dietary supplementation of L-carnosine prevents ischemia/reperfusion-induced renal injury in rats Biol Pharm Bull 28 2005 361 363
125. M.A. Babizhayev, A.I. Deyev, and V.N. Yermakova N-acetylcarnosine, a natural histidine-containing dipeptide, as a potent ophthalmic drug in treatment of human cataracts Peptides 22 2001 979 994
126. M.A. Babizhayev, A.I. Deyev, and V.N. Yermakova Efficacy of N-acetylcarnosine in the treatment of cataracts Drugs R D 3 2002 87 103
127. M.A. Babizhayev Rejuvenation of visual functions in older adult drivers and drivers with cataract during a short-term administration of N-acetylcarnosine lubricant eye drops Rejuvenation Res 7 2004 186 198
128. M.A. Babizhayev, A.I. Deyev, and V.N. Yermakova Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes Drugs R D 5 2004 125 139
129. E. Fosslien Mitochondrial medicine-molecular pathology of defective oxidative phosphorylation Ann Clin Lab Sci 31 2001 25 67
130. J.K. Sandhu, S. Pandey, and M. Ribecco-Lutkiewicz Molecular mechanisms of glutamate neurotoxicity in mixed cultures of NT2-derived neurons and astrocytes: protective effects of coenzyme Q10 J Neurosci Res 72 2003 691 703
131. L. Papucci, N. Schiavone, and E. Witort Coenzyme Q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical-scavenging property J Biol Chem 278 2003 28220 28228
132. C.W. Shults, D. Oakes, and K. Kieburtz Effects of coenzyme Q(10) in early Parkinson disease-evidence of slowing of the functional decline Arch Neurol 59 2002 1541 1552
133. A.U. Bayer, O.N. Keller, and F. Ferrari Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease Am J Ophthalmol 133 2002 135 137
134. E. Cho, S. Hung, and W.C. Willett Prospective study of dietary fat and the risk of age-related macular degeneration Am J Clin Nutr 73 2001 209 218
135. J.M. Seddon, B. Rosner, and R.D. Sperduto Dietary fat and risk for advanced age-related macular degeneration Arch Ophthalmol 119 2001 1191 1199
136. O. Miyauchi, A. Mizota, and E. Adachi-Usami Protective effect of docosahexaenoic acid against retinal ischemic injury: an electroretinographic study Ophthalmic Res 33 2001 191 195
137. A. Mizota, E. Sato, and M. Taniai Protective effects of dietary docosahexaenoic acid against kainate-induced retinal degeneration in rats Invest Ophthalmol Vis Sci 42 2001 216 221
138. K. Murayama, S. Yoneya, and O. Miyauchi Fish oil (polyunsaturated fatty acid) prevents ischemic-induced injury in the mammalian retina Exp Eye Res 74 2002 671 676
139. E.L. Berson, B. Rosner, and M.A. Sandberg Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses Arch Ophthalmol 122 2004 1306 1314
140. I. Azumi, H. Kosaki, and H. Nakatani Effects of methylcobalamin (Methylcobal) on the visual field of chronic glaucoma-a multicenter open study Folia Ophthalmol Jpn 34 1983 873 878
141. Y. Yamazaki, F. Hayamizu, and C. Tanaka Effects of long-term methylcobalamin treatment on the progression of visual field defects in normal-tension glaucoma Curr Therap Res 61 2000 443 451
142. M. Kikuchi, S. Kashii, and Y. Honda Protective effects of methylcobalamin, a vitamin B12 analog, against glutamate-induced neurotoxicity in retinal cell culture Invest Ophthalmol Vis Sci 38 1997 848 854
143. X. Kong, X. Sun, and J. Zhang The protective role of Mecobalamin following optic nerve crush in adult rats Yan Ke Xue Bao 20 2004 171 177
144. T.L. Wadsworth, and D. Koop Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide Chem Biol Interact 137 2001 43 58
145. T.L. Wadsworth, T.L. McDonald, and D.R. Koop Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha Biochem Pharmacol 62 2001 963 974
146. H. Dok-Go, K.H. Lee, and H.J. Kim Neuroprotective effects of antioxidative flavonoids, quercetin, (+)-dihydroquercetin and quercetin 3-methyl ether, isolated from Opuntia ficus-indica var. saboten Brain Res 965 2003 130 136
147. J.F. Su, C.J. Guo, and J.Y. Wei Protection against hepatic ischemia-reperfusion injury in rats by oral pretreatment with quercetin Biomed Environ Sci 16 2003 1 8
148. G. Tezel, and M. Wax Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells J Neurosci 20 2000 8693 8700
149. T. Ueda, T. Ueda, and D. Armstrong Preventive effect of natural and synthetic antioxidants on lipid peroxidation in the mammalian eye Ophthalmic Res 28 1996 184 192
150. H. Orhan, S. Marol, and I.F. Hepsen Effects of some probable antioxidants on selenite-induced cataract formation and oxidative stress-related parameters in rats Toxicology 139 1999 219 232